Biotech · Private company · La Jolla, CA, US

Tega Therapeutics, Inc.

Track this companyFree. Adds Tega Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards3

Activities and Biophysical Properties of Heparins, Engineered to Reduce HITFiscal year 2026 · $498.1KNIH RePORTER 1R43HL184653-01 · fetched Nov 12, 2026
Title: New Clinical Biomarkers for GM1 GamgliosidosisFiscal year 2025 · $500KNIH RePORTER 1R43NS139721-01A1 · fetched Nov 12, 2026
Testing Novel Advancements to Recombinant Heparin ProductionFiscal year 2024 · $355.2KNIH RePORTER 1R43HL172567-01 · fetched Nov 12, 2026